Deutsch English Français

Contact

EP3239131

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3239131

EP3239131 - NEW COMPOUNDS WITH ACTIVITY THAT PROTECTS AGAINST THE ACTION OF TOXINS AND VIRUSES IN INTRACELLULAR ACTION MODE [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 11.05.2021 Database last updated on 14.11.2024
Former	Request for examination was made Status updated on 04.05.2018
Former	The application has been published Status updated on 29.09.2017
Most recent event Tooltip	11.05.2021	Application deemed to be withdrawn	published on 09.06.2021 [2021/23]
Applicant(s)	For all designated states Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment "Le Ponant D" 25, Rue Leblanc 75015 Paris / FR
	[N/P]
Former [2017/44]	For all designated states Commissariat à l'Energie Atomique et aux Energies Alternatives Bâtiment "Le Ponant D" 25, rue Leblanc 75015 Paris / FR
Inventor(s)	01 / LOPEZ, Roman 6, rue Eliane Jeannin Garreau 92130 ISSY-LES-MOULINEAUX / FR
	02 / HEBBE, Séverine 8, rue cannebiere 75012 PARIS / FR
	03 / GILLET, Daniel 3, rue Jean-Charles Persil 92160 ANTONY / FR
	04 / BARBIER, Julien 8 résidence les Fonds Fanettes 91190 GIF SUR YVETTE / FR
	[2017/50]
Former [2017/44]	01 / LOPEZ, Roman 12 rue Ernest Renan 92130 ISSY-LES-MOULINEAUX / FR
	02 / HEBBE, Séverine 205 bis avenue Daumesnil 75012 PARIS / FR
	03 / GILLET, Daniel 168 rue du Temple 75003 PARIS / FR
	04 / BARBIER, Julien 8 résidence les Fonds Fanettes 91190 GIF SUR YVETTE / FR
Representative(s)	Gevers & Orès Immeuble le Palatin 2 3 Cours du Triangle CS 80165 92939 Paris La Défense Cedex / FR
	[N/P]
Former [2017/44]	Gevers & Orès 41 avenue de Friedland 75008 Paris / FR
Application number, filing date	17172035.2	17.06.2009
	[2017/44]
Priority number, date	EP20080290570	17.06.2008 Original published format: EP 08290570
	[2017/44]
Filing language	FR
Procedural language	FR
Publication	Type:	A1 Application with search report
	No.:	EP3239131
	Date:	01.11.2017
	Language:	FR
	[2017/44]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	15.09.2017
Classification	IPC:	C07C215/10, C07C217/58, C07C229/14, C07C233/06, C07C237/40, C07C271/56, C07C311/20, C07C35/02, C07D209/04, C07D213/38, C07D221/22, C07D239/20, A61P39/02, A61K31/137, A61K31/17	[2017/44]
	CPC:	A61K31/167 (EP,US); C07D451/02 (EP,US); A61K31/341 (EP,US); A61K31/5513 (EP,US); A61P1/00 (EP); A61P1/08 (EP); (+) A61P1/12 (EP); A61P1/18 (EP); A61P13/12 (EP); A61P25/00 (EP); A61P29/00 (EP); A61P31/12 (EP); A61P39/02 (EP); A61P7/04 (EP); C07C211/27 (EP,US); C07C211/38 (US); C07C215/10 (EP,US); C07C215/42 (EP,US); C07C215/44 (EP,US); C07C217/16 (EP,US); C07C217/58 (EP,US); C07C229/14 (EP,US); C07C229/22 (EP,US); C07C229/38 (EP,US); C07C229/48 (EP,US); C07C233/06 (EP,US); C07C233/58 (US); C07C233/65 (EP,US); C07C237/40 (EP,US); C07C251/24 (EP,US); C07C271/56 (EP,US); C07C275/28 (EP,US); C07C317/14 (US); C07C335/02 (US); C07D209/14 (EP,US); C07D213/38 (EP,US); C07D215/12 (EP,US); C07D233/10 (EP,US); C07D233/58 (EP,US); C07D233/61 (EP,US); C07D233/64 (EP,US); C07D235/08 (EP,US); C07D243/12 (EP,US); C07D243/24 (EP,US); C07D245/06 (EP,US); C07D249/06 (EP,US); C07D307/42 (EP,US); C07D307/52 (EP,US); C07D317/46 (EP,US); C07D317/58 (EP,US); C07D317/62 (EP,US); C07D317/66 (EP,US); C07D333/20 (EP,US); C07D401/04 (EP,US); C07D453/02 (EP,US); C07D471/08 (EP,US); C07D487/04 (EP,US); C07C2601/08 (US); C07C2602/46 (US); C07C2603/74 (US); Y02A50/30 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2018/23]
Former [2017/44]	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR
Title	German:	NEUE VERBINDUNGEN MIT GEGEN DIE WIRKUNG VON TOXINEN UND VIREN IM INTRAZELLULÄREN AKTIONSMODUS SCHÜTZENDER WIRKUNG	[2017/44]
	English:	NEW COMPOUNDS WITH ACTIVITY THAT PROTECTS AGAINST THE ACTION OF TOXINS AND VIRUSES IN INTRACELLULAR ACTION MODE	[2017/44]
	French:	NOUVEAUX COMPOSÉS AYANT UNE ACTIVITE PROTECTRICE VIS-A-VIS DE L'ACTION DE TOXINES ET DE VIRUS AU MODE D'ACTION INTRACELLULAIRE	[2017/44]
Examination procedure	19.05.2017	Date on which the examining division has become responsible
	27.04.2018	Amendment by applicant (claims and/or description)
	27.04.2018	Examination requested [2018/23]
	12.01.2021	Application deemed to be withdrawn, date of legal effect [2021/23]
	02.02.2021	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2021/23]
Parent application(s) Tooltip	EP09766019.5 / EP2297088
Fees paid	Renewal fee
	19.05.2017	Renewal fee patent year 03
	19.05.2017	Renewal fee patent year 04
	19.05.2017	Renewal fee patent year 05
	19.05.2017	Renewal fee patent year 06
	19.05.2017	Renewal fee patent year 07
	19.05.2017	Renewal fee patent year 08
	19.05.2017	Renewal fee patent year 09
	28.05.2018	Renewal fee patent year 10
	27.05.2019	Renewal fee patent year 11
	Penalty fee
	Additional fee for renewal fee
	30.06.2020	12 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A]WO9828298 (RES DEV FOUNDATION [US]) [A] 1-15 * the whole document *;
		[XAI] - VACZI LAJOS ET AL, "Antiviral effect of 1-aminoadamantane derivatives in vitro", ACTA MICROBIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE,, (19730101), vol. 20, no. 3, ISSN 0001-6187, pages 241 - 247, XP009195110 [X] 1,2,4-9 * page 243 - page 246; tables I/A, I/B,II/A,II/B * [A] 10-15 [I] 3
		[XI] - DUBOWCHIK G M ET AL, "Reversal of doxorubicin resistance and catalytic neutralization of lysosomes by a lipophilic imidazole", BIOCHIMICA ET BIOPHYSICA ACTA (BBA) - BIOMEMBRANES, ELSEVIER, AMSTERDAM, NL, vol. 1191, no. 1, doi:10.1016/0005-2736(94)90237-2, ISSN 0005-2736, (19940420), pages 103 - 108, (19940420), XP023354425 [X] 1,5,7 * page 104; figure 1; compounds 4-7 * [I] 4,8,9 DOI: http://dx.doi.org/10.1016/0005-2736(94)90237-2
		[X] - SZTARICSKAI F ET AL, "Synthese und virushemmende in-vitro-Wirkung neuerer 1-substituierter Adamantanderivate", DIE PHARMAZIE: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES, GOVI VERLAG PHARMAZEUTISCHER VERLAG GMBH, DE, (19750101), vol. 30, no. 9, ISSN 0031-7144, pages 571 - 581, XP002101986 [X] 1,2,5-8 * page 571 - page 580; tables 1-7 *
		[X] - BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE, Database accession no. 7077664, XP002507835 [X] 1,5 * abstract *
		[ ] - CHIMIRRI ET AL., FARMACO, (1994), vol. 49, no. 10, pages 649 - 652
		[X] - BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE, Database accession no. 2809387, XP002507837 [X] 5 * abstract *
		[ ] - OLAH ET AL., SYNTHESIS, (1979), pages 274 - 276
		[X] - BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE, Database accession no. 2867134, XP002507839 [X] 1,5,7,8 * abstract *
		[ ] - KLIMOCHKIN ET AL., KHIMIKO FARMATSEVTICHESKII ZHURNAL, (1991), vol. 25, no. 7, pages 49 - 51
		[X] - BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE, Database accession no. 2375351, XP002507836 [X] 1-3,6 * abstract *
		[ ] - ALDRICH ET AL., J.MED.CHEM., (1971), no. 14, pages 535 - 543
		[X] - BEILSTEIN, BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE, Database accession no. 9137691, XP002507828 [X] 5,6 * abstract *
		[ ] - SALVATORE ET AL., J.ORG.CHEM., (2002), vol. 67, no. 3, pages 674 - 683
		[A] - KOLOCOURIS N ET AL, "Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, (19960101), vol. 39, no. 17, doi:10.1021/JM950891Z, ISSN 0022-2623, pages 3307 - 3318, XP002449961 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1021/jm950891z
		[A] - W.L. DAVIES ET AL., "Antiviral Activity of 1-Adamantanamine (Amantadine)", SCIENCE, (1964), vol. 144, pages 862 - 863, XP002507819 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1126/science.144.3620.862
		[AD] - ROBERTUS ET AL., "Structure-based Identification of a Ricin Inhibitor", J. MOL. BIOL., (1997), no. 266, pages 1043 - 1049, XP004464340 [AD] 1-15 * the whole document * DOI: http://dx.doi.org/10.1006/jmbi.1996.0865
		[A] - A. M. SANCHEZ ET AL, "Amiodarone and Bepridil Inhibit Anthrax Toxin Entry into Host Cells", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, (20070701), vol. 51, no. 7, doi:10.1128/AAC.01184-06, ISSN 0066-4804, pages 2403 - 2411, XP055394666 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1128/AAC.01184-06
	by applicant	US6869787
		- FAINES, P.O.; SANDVIG, K., CURR. OPIN. CELL. BIOL., (2000), vol. 12, page 407
		- LORD, J.M.; ROBERTS, L.M.; ROBERTUS, J.D., FASEB J., (1994), vol. 8, page 201
		- MILLER, D.; RAVIKUMAR, K.; SHEN, H.; SUH, J.; KERWIN, S.; ROBERTUS, J.D., J. MED. CHEM., (2002), vol. 45, page 90
		- YAN, X. ET AL., J. MOL. BIOL., (1997), vol. 266, page 1043
		- SCHRAMM, V.L. ET AL., BIOCHEMISTRY, (2001), vol. 40, no. 23, page 6845
		- RODAY, S. ET AL., BIOCHEMISTRY, (2004), vol. 43, page 4923
		- STURM, M.B.; RODAY S.; SCHRAMM, V.L., J. AM. CHEM. SOC., (2007), vol. 129, pages 5544 - 5550
		- HESSELBERTH, J. R.; MILLER, D.; ROBERTUS, J.D.; ELLINGTON, A. D., J. BIOL. CHEM., (2000), vol. 275, page 4937
		- LEMLEY, P.V.; AMANATIDES, P.; WRIGHT, D.C., HYBRIDOMA, (1994), vol. 13, page 417
		- GUO, J.W.; SHEN, B.F.; FENG, J.N.; SUN, Y.X.; YU, M.; HU, M.R., HYBRIDOMA, (2005), vol. 24, page 263
		- FURUKAWA-STOFFER, T.L.; MAH, D.C.; CHERWONOGRODZKY, J.W.; WESELAKE, R.J., HYBRIDOMA, (1999), vol. 18, page 505
		- RIVERA-SAGREDO, A.; SOLIS, D.; DIAZ-MAURIRO, T.; JIMENEZ-BARBERO, J.; MARTIN-LOMES, M., EUR. J. BIOCHEM., (1991), vol. 197, page 217
		- DAWSON, R.M; ALDERTON, M.R.; WELLS, D.; HARTLEY, P.G. J., APPL. TOXICOL., (2006), vol. 26, page 247
		- SAENZ, J.B.; DOGGETT, T.A.; HASLAM, D,B., "Identification and Characterization of Small Molecules That Inhibit Intracellular Toxin Transport", INFECT. IMMUN., (2007), vol. 75, doi:doi:10.1128/IAI.00442-07, pages 4552 - 4561, XP002529419 DOI: http://dx.doi.org/10.1128/IAI.00442-07
		- SIECZKARSKI, S.B.; WHITTAKER, G.R., "Dissecting virus entry via endocytosis", J. GEN. VIROL., (2002), vol. 83, page 1535, XP002572408

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p